Liquid chromatography coupled with high resolution mass spectrometry reveals the inhibitory effects of Huangkuisiwu formula on biosynthesis of protein-binding uremic toxins in rats with chronic kidney disease DOI
Jianping Li, Yumeng Wang, Chengxi Li

и другие.

Journal of Chromatography B, Год журнала: 2024, Номер 1252, С. 124445 - 124445

Опубликована: Дек. 28, 2024

Язык: Английский

3'-Sialyllactose and B. infantis synergistically alleviate gut inflammation and barrier dysfunction by enriching cross-feeding bacteria for short-chain fatty acid biosynthesis DOI Creative Commons

Mingzhi Yang,

Zipeng Jiang, Lin Zhou

и другие.

Gut Microbes, Год журнала: 2025, Номер 17(1)

Опубликована: Апрель 7, 2025

Ulcerative colitis (UC) poses significant threats to human health and quality of life worldwide, as it is a chronic inflammatory bowel disease. 3'-sialyllactose (3'-SL) key functional component milk oligosaccharides. This study systematically evaluates the prebiotic effects 3'-SL its therapeutic potential in combination with Bifidobacterium infantis (B. infantis) for UC. The findings reveal that B. synergistically mitigate intestinal inflammation barrier dysfunction by promoting production short-chain fatty acids (SCFAs) through cross-feeding mechanisms among gut microbiota. Individually, 3'-SL, infantis, synbiotic treatment all effectively alleviated UC symptoms, including reduced weight loss, improved disease activity scores, prevention colon shortening. Histopathological immunofluorescence analyses further demonstrated significantly ameliorated colonic injury, enhanced function, restored goblet cell counts, increased glycoprotein content crypt cells, upregulated expression tight junction proteins (ZO-1, occludin, claudin-1). Notably, outperformed individual components better restoring microbiota balance, elevating SCFA levels, modulating serum cytokine profiles, thereby reducing inflammation. These provide mechanistic insights into protective underscore other disorders.

Язык: Английский

Процитировано

0

Postbiotics and extracellular polysaccharides of Lacticaseibacillus rhamnosus LRa05 alleviate loperamide-induced constipation via gut microbiota DOI
Jingxin Zhang, Ning Wang, Liyuan Yun

и другие.

Food Bioscience, Год журнала: 2025, Номер 68, С. 106651 - 106651

Опубликована: Апрель 22, 2025

Язык: Английский

Процитировано

0

Coix Seed Polysaccharide Mitigates Ulcerative Colitis in Mice through the Modulation of Gut Microbiota and Improvement of Intestinal Metabolism Balance DOI
Zhong‐Hao Ji,

Wen‐Yin Xie,

Hongyu Wu

и другие.

Journal of Agricultural and Food Chemistry, Год журнала: 2025, Номер unknown

Опубликована: Апрель 24, 2025

Ulcerative colitis (UC) is a chronic inflammatory bowel disease with rising incidence globally, whereas existing treatments exhibit significant limitations. Coix seed polysaccharide (CSP), component of traditional Chinese medicine known for its immunomodulatory and antioxidant properties, has not been thoroughly investigated role in UC. In this study, CSP was prepared via water extraction ethanol precipitation, protective effects mechanisms were evaluated using dextran sulfate sodium salt (DSS)-induced UC mouse model. The results demonstrated that significantly ameliorated DSS-induced symptoms, including weight loss, an elevated Disease Activity Index, colon shortening, increased levels cytokines, intestinal barrier damage. Moreover, reshaped the gut microbiota dysbiosis by increasing microbial diversity regulating abundance specific genera, such as Anaerotruncus. Metabolomic analysis revealed modulated 116 metabolites, particularly enhancing beneficial metabolite 3-hydroxybutyrate. Importantly, preventive effect on dependent could be transferred fecal transplantation. This study demonstrates CSP, microecology-regulating polysaccharide, effectively modulates alleviates symptoms These findings support potential dietary supplement prevention underscore value development medicinal foods functional food applications.

Язык: Английский

Процитировано

0

Effects of Abelmoschus manihot (L.) and its combination with irbesartan in the treatment of diabetic nephropathy via the gut–kidney axis DOI Creative Commons
Hongmei Yu, Haitao Tang,

Rengui Saxu

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Окт. 28, 2024

Background Clinical observations have recently shown that Abelmoschus manihot (L.) in the form of Huangkui capsule (HKC) and combination with irbesartan (EB) is an effective therapy for diabetic nephropathy (DN) patients type 2 diabetes (T2D). The present study aims to explore mechanisms underlying therapeutic efficacies HKC its EB DN via gut-kidney axis. Methods HKC, EB, their or vehicle were administered db/db mice, which animal model T2D DN. Comparative analyses gut microbiota, serum metabolites, kidney transcriptomics before after drug administration performed. Results After treatment 4 weeks, urinary albumin-to-creatinine ratios decreased significantly mice In terms abundances Faecalitalea, Blautia, Streptococcus increased but those Bacteroidetes, Firmicutes, Enterobacteriaceae, Desulfovibrio decreased. Parallelly, mainly including quercetin 3′-glucuronide L-dopa, elevated while cortisol cytochalasin B reduced. Furthermore, S100a8 , S100a9 Trem1 Mmp7 genes kidneys downregulated. These altered elements associated proteinuria/albuminuria reduction. However, had no effects on changes blood pressure specific differentially expressed kidneys. Conclusion provides experimental evidence regulates circulating renal gene activities, are useful better understanding action A. through

Язык: Английский

Процитировано

0

Liquid chromatography coupled with high resolution mass spectrometry reveals the inhibitory effects of Huangkuisiwu formula on biosynthesis of protein-binding uremic toxins in rats with chronic kidney disease DOI
Jianping Li, Yumeng Wang, Chengxi Li

и другие.

Journal of Chromatography B, Год журнала: 2024, Номер 1252, С. 124445 - 124445

Опубликована: Дек. 28, 2024

Язык: Английский

Процитировано

0